Evidence map›Paper›PMID 38282060›Full record

ArticleScientific reports2024

Response score-based protein structure analysis for cancer prediction aided by the Internet of Things.

Omar Alruwaili, Amr Yousef, Touqeer A Jumani, Ammar Armghan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Omar AlruwailiDepartment of Computer Engineering and Networks, College of Computer and Information Science, Jouf University, 72388, Sakaka, Saudi Arabia.
Amr YousefElectrical Engineering Department, University of Business and Technology, 23435, Ar Rawdah, Jeddah, Saudi Arabia.
Touqeer A JumaniDepartment of Electrical Engineering, Mehran University of Engineering and Technology, SZAB Campus, Khairpur Mirs, 66020, Pakistan.
Ammar ArmghanDepartment of Electrical Engineering. College of Engineering, Jouf University, 72388, Sakaka, Saudi Arabia. aarmghan@ju.edu.sa.
Al Jouf University · SAAlexandria University · EGMehran University of Engineering and Technology · PK

Funding

Al Jouf University Fast-track Research Funding Program.
6 · The paper itself

Abstract

Medical diagnosis through prediction and analysis is par excellence in integrating modern technologies such as the Internet of Things (IoT). With the aid of such technologies, clinical assessments are eased with protracted computing. Specifically, cancer research through structure prediction and analysis is improved through human and machine interventions sustaining precision improvements. This article, therefore, introduces a Protein Structure Prediction Technique based on Three-Dimensional Sequence. This sequence is modeled using amino acids and their folds observed during the pre-initial cancer stages. The observed sequences and the inflammatory response score of the structure are used to predict the impact of cancer. In this process, ensemble learning is used to identify sequence and folding responses to improve inflammations. This score is correlated with the clinical data for structures and their folds independently for determining the structure changes. Such changes through different sequences are handled using repeated ensemble learning for matching and unmatching response scores. The introduced idea integrated with deep ensemble learning and IoT combination, notably employing stacking method for enhanced cancer prediction precision and interdisciplinary collaboration. The proposed technique improves prediction precision, data correlation, and change detection by 11.83%, 8.48%, and 13.23%, respectively. This technique reduces correlation time and complexity by 10.43% and 12.33%, respectively.

Indexed as

Antifibrinolytic AgentsInternet of ThingsNeoplasmsAmino AcidsCorrelation of DataHumansHydrolasesAmino AcidsAntifibrinolytic AgentsHydrolases

Identifiers

PMID38282060
PMCPMC10822874
OpenAlexW4391287597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.